8 Best Fast Growing Penny Stocks to Buy Right Now
On May 4, Gregory Daco, EY-Parthenon Chief Economist, joined CNBC's 'Squawk Box' to discuss the current state of the US economy and the Fed's likely trajectory.
Ovid Therapeutics Inc. (OVID)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 10,714,000 | $23,785,080 | 0.25% | |
| 2. | Adage Capital Management Phill Gross And Robert Atchinson | 6,163,781 | $13,683,594 | +77% | 0.02% |
| 3. | Balyasny Asset Management Dmitry Balyasny | 5,533,073 | $12,283,422 | +1603% | 0.02% |
| 4. | ADAR1 Capital Management Daniel Schneeberger | 4,544,113 | $10,087,931 | +7% | 0.59% |
| 5. | Saturn V Capital Management Xiaoying Tian | 4,166,666 | $9,249,999 | +67% | 1.68% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.73 | 6,810 | $4,971.30 | 34,935 | 2025-01-27 | Filing | |
| $2.76 | 18,248 | $50,364.48 | 3,616,715 | 2024-03-18 | Filing | |
| $5.84 | 8,488 | $49,569.92 | 5,792,530 | 2020-08-28 | Filing | |
| $2.50 | 2,000,000 | $5,000,000.00 | 5,750,000 | 2019-10-08 | Filing | |
| $2.50 | 60,000 | $150,000.00 | 4,736,529 | 2019-10-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.45 | 11,656 | $16,901.20 | 61,750 | 2026-02-23 | Filing | |
| $1.45 | 8,541 | $12,384.45 | 88,188 | 2026-02-23 | Filing | |
| $0.56 | 5,279 | $2,956.24 | 73,406 | 2025-02-26 | Filing | |
| $0.56 | 3,902 | $2,185.12 | 67,973 | 2025-02-26 | Filing | |
| $2.15 | 17,344 | $37,289.60 | 0 | 2022-09-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 10,714,000 | $23,731,510 | 0.01% | |
| 2. | 10,636,318 | $23,612,626 | 1.22% | |
| 3. | 9,916,911 | $22,015,542 | 0.36% | |
| 4. | 5,258,246 | $11,673,306 | 0% | |
| 5. | 3,571,000 | $7,927,620 | 0.01% |
News See All
Is Ovid Therapeutics (OVID) One of the Best Fast Growing Penny Stocks to Buy According to Analysts?
Ovid Therapeutics Inc. (NASDAQ:OVID) is one of the best fast growing penny stocks to buy according to analysts.
7 Best Fast Growing Penny Stocks to Buy According to Analysts
On January 14, Lale Akoner, global market analyst at eToro, appeared on CNBC to state that 2026 is driven by rotation into small caps and advised diversification.
B. Riley Lifts Ovid Therapeutics (OVID) PT to $5 on Strong OV329 Phase 1 Data
Ovid Therapeutics Inc. (NASDAQ:OVID) is one of the hot stocks to buy with huge upside potential. On October 10, B.
12 Hot Stocks to Buy with Huge Upside Potential
On October 22, Vios Advisors’ Michael Bapis and BNY’s Alicia Levine joined CNBC's 'Closing Bell' to discuss the latest news affecting markets.
Lucid Capital Initiates Ovid Therapeutics Inc. (OVID) at Buy with $5.50 Target
Ovid Therapeutics Inc. (NASDAQ:OVID) is among the best US stocks under $10 to invest in. Analysts at Lucid Capital have begun coverage on Ovid Therapeutics Inc.
8 Best US Stocks Under $10 to Invest in
Everyone seeks a stock that has good upside potential, but a stock that is cheap and has good prospects - that’s what a steal deal looks like.
Ovid Therapeutics Sells Ganaxolone Royalty Rights for $7M to Immedica Pharma
Ovid Therapeutics Inc. (NASDAQ:OVID) is one of the best penny stocks under $1 to buy now. On June 25, Ovid Therapeutics announced a definitive agreement with Immedica Pharma AB.
12 Best Penny Stocks Under $1 to Buy Now
On July 18, Greg Tuorto of Goldman Sachs joined CNBC's 'Closing Bell' to state that the small-cap market is starting to show signs of life.
5 Oversold Biotech Stocks To Buy Right Now
In this article, we will be taking a look at 5 oversold biotech stocks to buy right now.
Hedge Fund Resource Center